Cases 31 - 40 of 74
Otsuka Pharmaceutical Co., Ltd. et al v. Hetero Labs Ltd. et al
as 1:2019cv01954
Defendant:
Hetero Labs Ltd., Honour Lab Ltd., Hetero Labs Ltd. Unit-V and others
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
as 1:2019cv01727
Counter Defendant:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant:
MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff:
Eden Biodesign, LLC.
Defendant:
Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al
as 1:2019cv01594
Defendant:
Hetero USA Inc. and Annora Pharma Private Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al. v. Hetero USA, Inc. et al.
as 1:2019cv00751
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Hetero Drugs, Ltd., Hetero USA Inc., Hetero Labs, Ltd. Unit-V and others
Cause Of Action: 35 U.S.C. § 271
Ferring Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
as 1:2019cv00634
Plaintiff:
Ferring Pharmaceuticals Inc. and Ferring International Center S.A.
Defendant:
Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit-V
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH v. Hetero USA Inc. et al
as 1:2019cv00211
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit-III and Hetero Labs Limited
Plaintiff:
Biogen International GmbH
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. Hetero Labs Limited et al
as 1:2019cv00178
Defendant:
Hetero Labs Limited Unit V, Hetero Labs Limited and Hetero USA Inc.
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Hetero USA Inc. et al
as 1:2019cv00014
Defendant:
Hetero USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Plaintiff:
Pharmacyclics LLC and Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al
as 1:2018cv01786
Defendant:
Hetero USA Inc. and Annora Pharma Private Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
